MagPro R20

MagPro R20

Product catalog summary
Overview: The MAGPRO R20 is a biphasic transcranial magnetic stimulation (TMS) device designed for clinical settings, particularly for a limited number of sessions per day. It is CE approved and FDA cleared for treating major depressive disorder and supports most clinical research protocols. The device offers a quick and simple protocol setup.
Specifications:
  • Max Repetition Rate: 20 pulses per second (pps)
  • Pulse Mode: Standard
  • Waveform: Biphasic
  • Current Direction: Normal
  • Ramp Up: No
Intended Use:
  • Diagnostic Use: Assists in diagnosing and monitoring central and peripheral nervous system diseases using Motor Evoked Potentials (MEP).
  • Therapeutic Use: Treats Major Depressive Disorder in adults who have not responded to at least two prior antidepressant medications.
Mechanical Data:
  • Dimensions (HxWxD): 150 x 390 x 440 mm / 5.9 x 15.3 x 17.3 in
  • Weight: 20 kg / 44 lbs
Environmental Data:
  • Operating Temperature: 10-30°C / 50-86°F
  • Storage Temperature: 5-50°C / 41-122°F
  • Operating Humidity: 30-60% RH
  • Storage Humidity: 20-80% RH
Power Supply:
  • Mains Voltage: 230V~, 50/60 Hz according to IEC 60601-1
  • Maximum Power Consumption: 800 VA, operational from 100V~ or 120V~ through a transformer
Ordering Information:
  • Ordering Number: 9016E0861
Additional Information: The product may not be approved by regulatory authorities in all regions. For more information, contact your local MagVenture distributor or visit www.magventure.com.
See more

Catalog excerpts

MagPro R20-1

Research. Treatment. Results. Max repetition rate 20 pps Waveform Biphasic Ramp up No Pulse mode Standard Current direction Normal Diagnostic Use The MagPro R20 is intended as an electro-physiological aid to assess diagnosis and to monitor diseases of the central and peripheral nervous system, based on the use of Motor Evoked Potentials (MEP). Therapeutic Use Treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from two prior antidepressant medications, at or above the minimal effective dose and duration in the current episode. Mechanical Data HxWxD Weight MAGPRO R20Biphasic Operating temperature Storage temperature Operating humidity Storage humidity The optimal choice when running a limited number of TMS sessions per day in a clinical setting but is also capable of running most of the used protocols for clinical research. CE approved and FDA cleared for treatment for major depressive disorder. Quick and simple protocol set-up. Power Supply Mains voltage 230V~,50/60 Hz according to IEC 60601-1 Maximum power consumption 800 VA, operation from 100V~ or 120V~ through transformer. Website: www.magventure.com Email: [email protected] Please note that this product may not be approved by regulatory authorities in your country/region. For more information, please consult with your local MagVenture distributor or subsidiary at www.magventure.com. This page was generated from magventure.com on 03/03 2020

 Open the catalog to page 1

All MagVenture catalogs and technical brochures

  1. MagPro R30

    1  Page

  2. MagPro X100

    1  Page

  3. MAGPRO R30

    1  Page

  4. MagPro® R20

    2  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.